BAL Lazio

Notizie

Ictus: le linee guida al femminile

Pubblicato mercoledì 2 Aprile 2014

La rivista Stroke pubbica le prime linee guida per la prevenzione dell’ictus nelle donne. Le linee guida sono state sviluppate dall’American Heart Association e dall’American Stroke Association.

Perché linee guida per la prevenzione dell’ictus specifiche per le donne?
Donne e uomini hanno molti fattori di rischio per l’ictus in comune, ma ci sono alcuni fattori sesso-specifici. Gravidanza, pre-eclampsia, diabete gestazionale, uso di contraccettivi orali, terapia ormonale sostitutiva possono aumentare nelle donne il rischio di ictus. Ci sono inoltre alcuni fattori di rischio più comuni nelle donne rispetto agli uomini: emicrania con aura, fibrillazione atriale, diabete.

Le nuove linee guida evidenziano i fattori di rischio specifici delle donne e forniscono le raccomandazioni per affrontarli sulla base delle delle evidenze scientifiche disponibili.

L’infografica che sintetizza le raccomandazioni delle linee guida.

Fonte:
Bushnell C, McCullough LD, Awad IA, et al (on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research). Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2014 Feb 6. doi: 10.1161/01.str.0000442009.06663.48

Per approfondire:
L’indagine di Cittadinanzattiva Mi sta a cuore

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Currie JM et al. Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the covid-19 pandemic. JAMA Netw Open 2021;4(4):e216147.

Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1375-1386.

Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1363-1374.

Zichi C et al. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. Eur j Canc 2021;149:49-60.

Seidler AN et al.; on behalf of the International Liaison Committee On Resuscitation Neonatal Life Support Task Force. Umbilical cord management for newborns <34 weeks' gestation: a meta-analysis. Pediatrics 2021; 147 (3) e20200576.

Gabrhelík R et al. Cannabis use during pregnancy and risk of adverse birth outcomes: a longitudinal cohort study. Eur Addict Res 2020. doi: 10.1159/000510821e

Ouldali N et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. February 1, 2021. Epub ahead of print. doi:10.1001/jama.2021.0694

Freedman RA et al. Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: multidisciplinary expert panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. Published online January 28, 2021. doi:10.1001/jamaoncol.2020.7582

Fontanella CA et al. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. Published online January 19, 2021. doi:10.1001/jamapediatrics.2020.5494

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.